Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)
China · Delayed Price · Currency is CNY 21.10
-0.76 (-3.48%)
Sep 10, 2026, 3:04 PM CST
SHE:002864 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 989.42 | 1,141 | 973.86 | 980.83 | 974.29 | 887.48 |
Revenue Growth | -9.44% | 17.15% | -0.71% | 0.67% | 9.78% | 32.40% |
Gross Profit Gross Profit Growth | 542.49 | 591.62 | 592.12 | 567.09 | 566.04 | 517.12 |
Operating Income Operating Income Growth | 98.4 | 86.81 | 106.53 | 113.11 | 113.1 | 103.05 |
Net Income Net Income Growth | 78.52 | 96.28 | 120.27 | 110.43 | 101.16 | 93.17 |
Earnings Per Share EPS Growth | 0.58 | 0.71 | 0.88 | 0.87 | 0.90 | 0.84 |
EPS Growth | -34.65% | -20.00% | 1.77% | -3.42% | 7.33% | 18.48% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Self-Produced Chinese Patent Medicine Self-Produced Chinese Patent Medicine Growth | 644.11 | 644.93 | 585.22 | 555.5 | 508.13 |
Chinese Herbal Pieces Chinese Herbal Pieces Growth | 235 | 91.27 | 23.23 | 20.54 | 23.76 |
Pharmaceutical Commercial Distribution Pharmaceutical Commercial Distribution Growth | 254.08 | 231.27 | 365.48 | 389.47 | 347.3 |
Health Products Health Products Growth | 2.14 | 0.96 | 3.72 | 5.45 | 4.56 |
Other Other Growth | 5.53 | 5.42 | 3.17 | 3.34 | - |
Total Total Growth | 1,141 | 973.86 | 980.83 | 974.29 | 887.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,197 | 1,095 | 1,169 | 1,102 | 823.44 | 419.3 |
Total Debt Total Debt Growth | 53.37 | 100.83 | 152.14 | 102.49 | 427.16 | 143.9 |
Net Cash (Debt) Net Cash Growth | 1,144 | 994.06 | 1,017 | 999.52 | 396.28 | 275.41 |
Net Cash Growth | 12.62% | -2.28% | 1.77% | 152.22% | 43.89% | -1.78% |
Net Cash Per Share Net Cash Per Share Growth | 8.42 | 7.31 | 7.48 | 7.87 | 3.53 | 2.48 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 176.91 | 63.01 | 156.59 | 104.05 | 125.36 | 116.04 |
Capital Expenditures CapEx Growth | -29.06 | -42.41 | -82.05 | -62.51 | -55.84 | -80.68 |
Free Cash Flow Free Cash Flow Growth | 147.85 | 20.6 | 74.54 | 41.53 | 69.53 | 35.36 |
Free Cash Flow Growth | 305.16% | -72.36% | 79.47% | -40.26% | 96.63% | 67.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 54.83% | 51.86% | 60.80% | 57.82% | 58.10% | 58.27% |
Operating Margin | 9.95% | 7.61% | 10.94% | 11.53% | 11.61% | 11.61% |
Pretax Margin | 9.81% | 9.55% | 14.06% | 13.18% | 12.23% | 12.29% |
Profit Margin | 7.94% | 8.44% | 12.35% | 11.26% | 10.38% | 10.50% |
FCF Margin | 14.94% | 1.81% | 7.65% | 4.23% | 7.14% | 3.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.269 | 0.269 | 0.192 | 0.169 | 0.154 | 0.139 |
Dividend Per Share Growth | -18.75% | 39.99% | 13.65% | 10.01% | 11.05% | 20.02% |
Dividend Yield | 1.28% | 1.15% | 0.84% | 0.59% | 0.53% | 0.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 37.81 | 33.92 | 26.59 | 36.65 | 32.81 | 28.77 |
Forward PE | - | 16.47 | 16.47 | 27.59 | 74.31 | 74.31 |
P/FCF Ratio | 20.36 | 158.52 | 42.90 | 97.45 | 47.73 | 75.80 |
PS Ratio | 3.04 | 2.86 | 3.28 | 4.13 | 3.41 | 3.02 |